These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 7919554)

  • 21. Current status of drug information centers.
    Beaird SL; Coley RM; Crea KA
    Am J Hosp Pharm; 1992 Jan; 49(1):103-6. PubMed ID: 1570848
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmaceutical services in U.S. hospitals in 1989.
    Raehl CL; Bond CA; Pitterle ME
    Am J Hosp Pharm; 1992 Feb; 49(2):323-46. PubMed ID: 1553999
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Timeliness of receipt of manufacturers' new product information.
    Murdoch LA; Lum L
    Can J Hosp Pharm; 1991 Oct; 44(5):235-8. PubMed ID: 10115576
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The development of a computerized LAN-based investigational drug information database.
    Gajewski LK; Vanscoy GJ; Dean JC; Bouzos CG
    Hosp Pharm; 1995 Dec; 30(12):1113, 1116-8, 1120. PubMed ID: 10153658
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ASHP guidelines on the provision of medication information by pharmacists.
    Am J Health Syst Pharm; 1996 Aug; 53(15):1843-5. PubMed ID: 8842315
    [No Abstract]   [Full Text] [Related]  

  • 26. Recommendations for improving the quality of care through stroke centers and systems: an examination of stroke center identification options: multidisciplinary consensus recommendations from the Advisory Working Group on Stroke Center Identification Options of the American Stroke Association.
    Adams R; Acker J; Alberts M; Andrews L; Atkinson R; Fenelon K; Furlan A; Girgus M; Horton K; Hughes R; Koroshetz W; Latchaw R; Magnis E; Mayberg M; Pancioli A; Robertson RM; Shephard T; Smith R; Smith SC; Smith S; Stranne SK; Kenton EJ; Bashe G; Chavez A; Goldstein L; Hodosh R; Keitel C; Kelly-Hayes M; Leonard A; Morgenstern L; Wood JO;
    Stroke; 2002 Jan; 33(1):e1-7. PubMed ID: 11779938
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of drug information request templates on pharmacy student compliance with the modified systematic approach to answering drug information questions.
    Lavsa SM; Corman SL; Verrico MM; Pummer TL
    Ann Pharmacother; 2009 Nov; 43(11):1795-801. PubMed ID: 19843836
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Revising a drug information center quality assurance program to conform to Joint Commission standards.
    Moody ML
    Am J Hosp Pharm; 1990 Apr; 47(4):792-4. PubMed ID: 2321654
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Drug information centres and their provision of decision support: The Scandinavian experience.
    Schjøtt J; Spigset O
    J Clin Pharm Ther; 2019 Jun; 44(3):489-492. PubMed ID: 30710370
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ASHP national survey of hospital-based pharmaceutical services--1992.
    Crawford SY; Myers CE
    Am J Hosp Pharm; 1993 Jul; 50(7):1371-404. PubMed ID: 8362870
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluating the accuracy of citations in drug promotional brochures.
    Keng A; Coley RM
    Ann Pharmacother; 1994 Nov; 28(11):1231-5. PubMed ID: 7849333
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Formalizing written communication by decentralized pharmacists with prescribers.
    Heitman D; Krivanek F
    Hosp Pharm; 1994 Dec; 29(12):1078, 1080, 1082-3. PubMed ID: 10138835
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ASHP national survey of pharmaceutical services in federal hospitals--1993.
    Crawford SY; Santell JP
    Am J Hosp Pharm; 1994 Oct; 51(19):2377-93. PubMed ID: 7847403
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Drug information quality assurance program used to appraise students' performance.
    Restino MS; Knodel LC
    Am J Hosp Pharm; 1992 Jun; 49(6):1425-9. PubMed ID: 1529983
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of ten specific questions on nationwide drug information center activity.
    Fisher JM
    Drug Inf J; 1985; 19(1):75-9. PubMed ID: 10270139
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Providence Health Plan call center: a case study in innovation and integration.
    Odermann M; Petras GJ; Cook J
    Healthc Inf Manage; 1998; 12(2):121-6. PubMed ID: 10182513
    [No Abstract]   [Full Text] [Related]  

  • 37. Practical approaches to quality assurance of clinical pharmacy programs: a review.
    Rodriguez LR; Weber C
    Top Hosp Pharm Manage; 1988 Feb; 7(4):24-34. PubMed ID: 10314264
    [No Abstract]   [Full Text] [Related]  

  • 38. Profile of drug information centers in the United States.
    McDonald JE
    Drug Inf J; 1982; 16(4):196-8. PubMed ID: 10260022
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quality assurance program for a hospital investigational-drug service.
    Tankanow RM; Savitsky ME; Volger BW; Ryan ML; Colvin CL
    Am J Hosp Pharm; 1989 May; 46(5):962-9. PubMed ID: 2729303
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A comparison of pharmaceutical manufacturers as a source of drug information to a telephone inquiry: generic vs brand.
    Generali JA; Hogan L
    Drug Inf J; 1983; 17(3):195-204. PubMed ID: 10265096
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.